Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Herun Innovation Pharmaceutical Technology Development is a biotechnology and pharmaceutical research company based in Beijing, China. The company specializes in the development of innovative ophthalmic treatments and the extraction of bioactive compounds from Traditional Chinese Medicine (TCM). Its core research focuses on recombinant humanized collagen-based eye drops for conditions like dry eye and inflammation, as well as TCM-derived therapies for glaucoma. Recognized as a high-tech enterprise, the company maintains a pipeline of patent-protected candidates and has advanced several programs into clinical development in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Herun Innovation Pharmaceutical Technology Development.